Dermapharm Holding SE (DMPHF) Stock Overview
Explore Dermapharm Holding SE’s financial performance, market position, analyst ratings, and future outlook.
Dermapharm Holding SE (DMPHF)
Key Financials
Key Financials
Market Cap
2.9B
P/E Ratio
19.04
EPS (TTM)
$2.21
ROE
0.21%
DMPHF Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Dermapharm Holding SE (DMPHF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 48.15, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $37.66.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 19.04 and a market capitalization of 2.9B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.